VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans
-
- Nitya Nair
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- Ningguo Feng
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- Lisa K. Blum
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- Mrinmoy Sanyal
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- Siyuan Ding
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- Baoming Jiang
- National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
-
- Adrish Sen
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- John M. Morton
- Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- Xiao-Song He
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- William H. Robinson
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- Harry B. Greenberg
- Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
書誌事項
- 公開日
- 2017-06-21
- DOI
-
- 10.1126/scitranslmed.aam5434
- 公開者
- American Association for the Advancement of Science (AAAS)
この論文をさがす
説明
<jats:p>Individual human VP4- and VP7-binding monoclonal antibodies mediate serotype cross-reactive neutralizing immunity to rotaviruses.</jats:p>
収録刊行物
-
- Science Translational Medicine
-
Science Translational Medicine 9 (395), 1-, 2017-06-21
American Association for the Advancement of Science (AAAS)